Related Experiment Video
Updated: Mar 28, 2026
08:09
Vessel-sparing Excision and Primary Anastomosis
Published on: January 7, 2019
12.2K
Repeat surgery after failed midurethral slings: a nationwide cohort study, 1998-2007
Margrethe Foss Hansen1, Gunnar Lose2, Ulrik Schiøler Kesmodel2
1Center for Clinical Epidemiology, South, Odense University Hospital and Research Unit of Clinical Epidemiology, Institute of Clinical Research, University of Southern Denmark, Odense, Denmark. mfoss@health.sdu.dk.
International Urogynecology Journal
|December 30, 2015
Summary
Repeat synthetic midurethral slings (MUS) were the most common reoperation after initial MUS failure. Urethral injection therapy was a frequent second choice for treating recurrent urinary incontinence in women.
Area of Science:
- Urology
- Female Pelvic Medicine and Reconstructive Surgery
Background:
- Synthetic midurethral slings (MUS) are a common surgical treatment for female stress urinary incontinence.
- Failure of synthetic MUS necessitates further surgical intervention, but patterns of subsequent treatment are not well-defined.
Purpose of the Study:
- To describe the choice of subsequent surgery after failure of synthetic midurethral slings (MUS).
- To analyze treatment patterns based on a nationwide population cohort.
Main Methods:
- Utilized the Danish National Patient Registry to identify women undergoing first-time synthetic MUS (1998-2007).
- Assessed repeat surgery for urinary incontinence within a 5-year follow-up period.
- Analyzed procedure codes for subsequent interventions.
Main Results:
- 6% of 5,820 women required reoperation after initial synthetic MUS.
- Repeat synthetic MUS was the most frequent reoperation (45.5%), followed by urethral injection therapy (36.7%).
- 82% of reoperations occurred at the same hospital department as the primary procedure.
Conclusions:
- Repeat synthetic MUS is the primary surgical choice following initial synthetic MUS failure.
- Urethral injection therapy is a common second-line treatment option.
- Healthcare delivery for reoperations often remains within the same clinical department.
